At the recent American Urological Association (AUA) annual meeting, focal therapies for localized prostate cancer took center ...

New research has identified specific blood-based biomarkers that can predict the failure of prostate cancer treatment in both hormone-sensitive and castration-resistant patients. The study ...

Former US President Joe Biden has been diagnosed with prostate cancer, his office said Sunday. Biden was seen by doctors last ...

Generally, prostate cancer survival rates are very good with a five-year survival rate of 97%. There are, however, a number of factors that can influence survival rates, particularly for men with ...

Gleason score 6 is the lowest grade of prostate cancer. This rating means that the prostate cancer is considered to be low- or very low-risk disease, or group 1. Most of these tumors are found during ...

the size of the cancer and whether it has spread (the stage) Doctors use the Grade score or Gleason score and other information to divide prostate cancer into 5 groups. This is called the Cambridge ...

Androgen deprivation is the mainstay of advanced prostate cancer treatment. Despite initial responses, almost all patients progress to castration-resistant prostate cancer (CRPC). The ...

The PSA test is a blood test that measures the amount of prostate specific antigen (PSA) in your blood. It can help to diagnose prostate cancer. Your doctor or nurse takes a sample of your blood. This ...

Metastasis-directed SABR has demonstrated benefit in oligometastatic castration-sensitive prostate cancer, but disease progression often occurs in bone. To assess whether adding Ra223 to SABR ...

The news was first reported by The New York Times. Further testing would be needed to determine if a nodule points to prostate cancer or is benign, meaning noncancerous. "Prostate cancer may ...

A new global prostate cancer awareness campaign developed by biopharmaceutical companies AstraZeneca (AZ) and Merck & Co. (MSD) has just been launched in the US and Canada: ‘Never Miss ...

Initial study results may be available as soon as the first half of 2026.